Skip to content

Effects of temporary eye closure on hand-eye coordination in basal cell carcinoma patients.

Effects of temporary eye closure on hand-eye coordination in basal cell carcinoma patients. - EyeCanMoveiT(2)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00031400
Enrollment
151
Registered
2023-03-01
Start date
2023-01-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C44.1

Interventions

Group 1: Eye cancer patients who are about to undergo medical treatment for removal of basal cell carcinoma of the eyelid followed by temporary closure of one eye (Hughes' plastic) will be followed ov

Sponsors

Universitätsklinikum Köln
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Diagnosis of basal cell carcinoma - Age = 18 years - Prior to surgical excision followed by eyelid reconstruction using Hughes' plastic surgery - Curative medical treatment approach or life expectancy at least 6 months - Good German language skills - Signed informed consent

Exclusion criteria

Exclusion criteria: - Failure to meet inclusion criteria - Shortened life expectancy of less than 6 months - All general diseases that do not allow sports activity in particular: - Clinically-manifest heart failure (NYHA III-IV). - Respiratory partial or global insufficiency - Permanent thrombocytopenia <10,000/µl, e.g., refractory autoimmune thrombocytopenia - Congenital or acquired thrombocytopathies or coagulation disorders. - Symptomatic CHD (clearance certificate required, stress ECG and cardiac ultrasound recommended if necessary) - Severe refractory hypertension - Uncontrollable COPD - Uncontrolled cerebral seizure disorder - Severe anemia (requiring transfusion). - Medical or mental condition that, in the opinion of the investigator, does not allow the patient to participate in the study or provide a legally binding signature on the informed consent form - Lack of willingness to store and share personal disease data as part of the protocol - Participation in another exercise therapy study

Design outcomes

Primary

MeasureTime frame
Testing will occur at 5 time points: Immediately before medical intervention, surgical eye closure (t0), immediately after medical intervention (t1), immediately before eye opening (t2), three weeks after opening (t3), and 6-month follow-up (t4). The primary endpoint, hand-eye coordination, will be assessed using the Purdue Pegboard Test (Lafayette Instruments, USA)

Secondary

MeasureTime frame
- Health-related quality of life - Indication-specific health-related quality of life - Endurance capacity - Static and dynamic balance - Movement behavior/physical activity - Psychological well-being (depression and anxiety) - Neck pain - Employment and financial status

Countries

Germany

Contacts

Public ContactFreerk T. Baumann

Universitätsklinikum Köln

freerk.baumann@uk-koeln.de+49221 478-42643

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026